chitosan has been researched along with n-acetylneuraminic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 7 (63.64) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, H; Itoh, M; Makimura, Y; Masui, A; Matahira, Y; Shibata, M; Umekawa, M; Umemura, M; Yamamoto, K; Yamazaki, K | 1 |
| Dhavale, D; Henry, JE | 1 |
| Carrizalez-Alvarez, SA; Gregorio-Jauregui, KM; Ilyina, A; López, RG; Martinez, JL; Rivera-Salinas, JE; Saade, H; Segura, EP | 1 |
| Baieli, MF; Cascone, O; Hirsch, DB; Martinez, MJ; Miranda, MV; Pilosof, AM; Urtasun, N; Wolman, FJ | 1 |
| Du, YZ; Ji, JS; Jin, FY; Qi, J; Shen, QY; Shu, GF; Wang, XJ; Xu, XL; Ying, XY | 1 |
| Chen, Q; Jin, Q; Liu, Z; Shen, J; Yang, Y; Zhu, J; Zhu, W | 1 |
| Huang, YM; Kong, SZ; Li, SD; Liu, HZ; Luo, H; Ouyang, QQ; Quan, WY | 1 |
| Gupta, U; Kumar, V; Nakhate, KT; Rana, R; Rani, S | 1 |
| Chen, X; Ge, Y; Hu, D; Li, Z; Pang, M; Sun, L; Wang, X; Wu, J; Yao, J | 1 |
| Abadi, B; Adeli-Sardou, M; Ahmadi-Zeidabadi, M; Ameri, A; Amirinejad, M; Forootanfar, H; Khazaeli, P; Nokhodchi, A; Ranjbar, M | 1 |
| Chawla, R; Kumar, A; Kumar, K; Mishra, M; Rawat, SG | 1 |
11 other study(ies) available for chitosan and n-acetylneuraminic acid
| Article | Year |
|---|---|
Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection.
Topics: Cell Line; Chitosan; Drug Design; Glucose; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Models, Molecular; Molecular Structure; N-Acetylneuraminic Acid; Orthomyxoviridae Infections | 2008 |
Evaluation of sialic acid-analogs for the attenuation of amyloid-beta toxicity.
Topics: Amyloid beta-Peptides; Antiparkinson Agents; Carbohydrate Metabolism; Carbohydrates; Cell Survival; Chitosan; Cytoprotection; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Models, Biological; N-Acetylneuraminic Acid; Neurons; Osmolar Concentration; Tumor Cells, Cultured | 2012 |
Extraction and immobilization of SA-α-2,6-Gal receptors on magnetic nanoparticles to study receptor stability and interaction with Sambucus nigra lectin.
Topics: Animals; Chitosan; Humans; Immobilized Proteins; Magnetite Nanoparticles; N-Acetylneuraminic Acid; Plant Lectins; Protein Binding; Protein Stability; Receptors, Cell Surface; Ribosome Inactivating Proteins; Swine; Trachea | 2014 |
Affinity chromatography matrices for depletion and purification of casein glycomacropeptide from bovine whey.
Topics: Adsorption; Amino Acids; Animals; Caseins; Cattle; Chitosan; Chromatography, Affinity; Glycosylation; Milk; N-Acetylneuraminic Acid; Peptide Fragments; Whey; Whey Proteins | 2017 |
Sialic acid-modified chitosan oligosaccharide-based biphasic calcium phosphate promote synergetic bone formation in rheumatoid arthritis therapy.
Topics: Arthritis, Rheumatoid; Chitosan; Humans; Hydroxyapatites; N-Acetylneuraminic Acid; Oligosaccharides; Osteogenesis | 2020 |
Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis.
Topics: Administration, Inhalation; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; CD8-Positive T-Lymphocytes; Chitosan; Drug Liberation; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mucins; N-Acetylneuraminic Acid; Nanocapsules; Protein Multimerization; Signal Transduction | 2021 |
Grafting of 18β-Glycyrrhetinic Acid and Sialic Acid onto Chitosan to Produce a New Amphipathic Chitosan Derivative: Synthesis, Characterization, and Cytotoxicity.
Topics: Cell Line; Chitosan; Glycyrrhetinic Acid; Humans; Materials Testing; N-Acetylneuraminic Acid; Solubility | 2021 |
Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chitosan; Drug Carriers; Lung Neoplasms; N-Acetylneuraminic Acid; Nanoparticles; Rats; Rats, Sprague-Dawley | 2021 |
Novel carboxymethyl chitosan/N-acetylneuraminic acid hydrogel for the protection of Pediococcus pentosaceus.
Topics: Chitosan; Hydrogels; Hydrogen-Ion Concentration; N-Acetylneuraminic Acid; Pediococcus pentosaceus | 2022 |
Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma cell lines.
Topics: Antineoplastic Agents; Cell Line; Chitosan; Glioblastoma; Humans; N-Acetylneuraminic Acid; Nanoparticles; Selenium | 2023 |
Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; Chitosan; ErbB Receptors; Gemcitabine; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; N-Acetylneuraminic Acid; Nanoparticles | 2023 |